SCHEMBL22378973

SCHEMBL22378973

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccccc1-c1ccccc1-c1cc(-n2c3ccccc3c3c(C#N)cccc32)ccc1C#N

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.31
TDP2 O95551 1/20 0.30
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22378082 1.00 KDM1A (0.31) KDM1ATDP2FNTAFNTB
SCHEMBL22379097 0.97 FNTA (0.32) KDM1ATDP2FNTAFNTB
SCHEMBL22378005 0.97 FNTA (0.32) KDM1ATDP2FNTAFNTB
SCHEMBL22153627 0.94 KDM1A (0.32) KDM1AFNTAFNTB
SCHEMBL22153951 0.94 KDM1A (0.32) KDM1AFNTAFNTB
SCHEMBL22153553 0.93 NR3C1 (0.32)
SCHEMBL22152621 0.93 NR3C1 (0.32)
SCHEMBL22379419 0.93 KDM4E (0.33)
SCHEMBL22377775 0.93 CCNB2 (0.33) KDM1AFNTAFNTB
SCHEMBL22377767 0.93 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 KDM1A 1099/4885TDP2 3777/4885FNTA 1561/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 KDM1A 1099/4885TDP2 3777/4885FNTA 1561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.